These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 11920570

  • 1. Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice.
    Kusuhara M, Matsue K, Edelbaum D, Loftus J, Takashima A, Matsue H.
    Eur J Immunol; 2002 Apr; 32(4):1035-43. PubMed ID: 11920570
    [Abstract] [Full Text] [Related]

  • 2. Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.
    Kusuhara M, Matsue H.
    Exp Dermatol; 2005 Apr; 14(4):273-80. PubMed ID: 15810885
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells.
    Matsue H, Matsue K, Kusuhara M, Kumamoto T, Okumura K, Yagita H, Takashima A.
    Blood; 2001 Dec 01; 98(12):3465-72. PubMed ID: 11719389
    [Abstract] [Full Text] [Related]

  • 4. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW, Hara H, Tesmann JP, Martin S, Simon JC.
    J Leukoc Biol; 2001 Apr 01; 69(4):548-54. PubMed ID: 11310840
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H, Edelbaum D, Hartmann AC, Morita A, Bergstresser PR, Yagita H, Okumura K, Takashima A.
    J Immunol; 1999 May 01; 162(9):5287-98. PubMed ID: 10228004
    [Abstract] [Full Text] [Related]

  • 6. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P, Serre K, Baillet M, Leserman L.
    J Immunol; 2002 Feb 01; 168(3):1172-80. PubMed ID: 11801652
    [Abstract] [Full Text] [Related]

  • 7. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S, Komita H, Sagawa Y, Ohno T, Toda G.
    Immunology; 2005 Aug 01; 115(4):451-61. PubMed ID: 16011514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Revealing the in vivo behavior of CD4+ T cells specific for an antigen expressed in Escherichia coli.
    Chen ZM, Jenkins MK.
    J Immunol; 1998 Apr 01; 160(7):3462-70. PubMed ID: 9531307
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V, Winkel K, Süss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K.
    J Immunol; 1996 Nov 01; 157(9):3819-27. PubMed ID: 8892611
    [Abstract] [Full Text] [Related]

  • 18. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.
    J Immunol; 1999 Jan 01; 162(1):144-51. PubMed ID: 9886380
    [Abstract] [Full Text] [Related]

  • 19. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells.
    Matsue H, Matsue K, Walters M, Okumura K, Yagita H, Takashima A.
    Nat Med; 1999 Aug 01; 5(8):930-7. PubMed ID: 10426318
    [Abstract] [Full Text] [Related]

  • 20. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy.
    Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Storozynsky E, Lord EM, Frelinger JG, Woodward JG.
    J Immunol; 2000 May 01; 164(9):4543-50. PubMed ID: 10779755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.